Due for re-check: the scheduled review date of 2026-09-04 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
62037-725-01 · Methylphenidate Hydrochloride Tablet, Extended Release · Teva Pharmaceuticals USA, Inc.
What is the package ndc for 62037-725-01 · Methylphenidate Hydrochloride Tablet, Extended Release · Teva Pharmaceuticals USA, Inc.?
For 62037-725-01 · Methylphenidate Hydrochloride Tablet, Extended Release · Teva Pharmaceuticals USA, Inc., package ndc is 62037-725-01; generic name is Methylphenidate Hydrochloride Tablet, Extended Release; manufacturer is Teva Pharmaceuticals USA, Inc; status is Current; availability now is Limited Availability, recorded from its source on 2026-09-01.
"initial_posting_date": "07/26/2023", "package_ndc": "62037-725-01", "generic_name": "Methylphenidate Hydrochloride Tablet, Extended Release", "contact_info": "800-545-8800", "availability": "Limited Availability", "related_info": "Estimated recovery: September 2026"
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 62037-725-01 verified
- Generic name
- Methylphenidate Hydrochloride Tablet, Extended Release verified
- Manufacturer
- Teva Pharmaceuticals USA, Inc. verified
- Status
- Current verified
- Availability now
- Limited Availability verified
- FDA note
- Estimated recovery: September 2026 verified
- Initial posting date
- 07/26/2023 verified
- Last update date
- 08/17/2026 verified
- Days in shortage
- 1133 our reading
- Reason for shortage
- Other verified
- Dosage form
- Tablet verified
- Therapeutic category
- Psychiatry verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/17/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Tablet", "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01)", "company_name": "Teva Pharmaceuticals USA, Inc.", "shortage_reason": "Other", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000